| Divis Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532488 |
NSE Symbol : DIVISLAB |
P/E(TTM) : 68.36 |
|
ISIN Demat : INE361B01024 |
Div & Yield% : 0.46 |
EPS(TTM) : 94.70 |
|
Book Value(₹) : 578.26 |
Market Cap(₹Cr) : 171,847.10 |
Face Value(₹) : 2.00 |
| Particulars | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 9,198.00 | 7,665.00 | 7,625.00 | 8,879.82 | 6,798.61 |
| Other Income | 352.00 | 337.00 | 349.00 | 111.26 | 62.53 |
| Stock Adjustments | 83.00 | 127.00 | -50.00 | 449.99 | 100.00 |
| Total Income | 9,633.00 | 8,129.00 | 7,924.00 | 9,441.07 | 6,961.14 |
| EXPENDITURE : | |||||
| Raw Materials | 3,827.00 | 3,270.00 | 3,035.00 | 3,499.18 | 2,416.47 |
| Power and Fuel Cost | 465.00 | 477.00 | 496.00 | 390.05 | 319.15 |
| Other Manufacturing Expenses | 276.00 | 299.00 | 285.00 | 255.38 | 202.29 |
| Selling and Administration Expenses | 449.00 | 367.00 | 402.00 | 340.16 | 292.53 |
| Miscellaneous Expenses | 74.00 | 137.00 | 55.00 | 40.95 | 37.69 |
| Employee Benefit Expenses | 1,210.00 | 1,067.00 | 953.00 | 926.55 | 808.68 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 3,332.00 | 2,512.00 | 2,698.00 | 3,988.80 | 2,884.33 |
| Interest | 2.00 | 4.00 | 2.00 | 1.73 | 1.81 |
| Gross Profit | 3,330.00 | 2,508.00 | 2,696.00 | 3,987.07 | 2,882.52 |
| Depreciation | 401.00 | 376.00 | 342.00 | 310.55 | 254.65 |
| Profit Before Tax | 2,929.00 | 2,132.00 | 2,354.00 | 3,676.52 | 2,627.87 |
| Current Tax | 793.00 | 511.00 | 438.00 | 637.20 | 609.05 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -73.00 | 45.00 | 108.00 | 90.78 | 64.10 |
| Reported Net Profit | 2,209.00 | 1,576.00 | 1,808.00 | 2,948.54 | 1,954.72 |
| Extraordinary Items | 0.73 | 0.74 | 3.07 | -1.65 | -2.45 |
| Adjusted Net Profit | 2,208.27 | 1,575.26 | 1,804.93 | 2,950.19 | 1,957.17 |
| Adjustment below Net Profit | -2.00 | -1.00 | 2.00 | 2.18 | 0.16 |
| Profit/Loss Balance carried down | 11,725.00 | 10,922.00 | 9,967.00 | 7,588.31 | 5,814.44 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 575.00 | 772.00 | 855.00 | 571.50 | 181.01 |
| P & L Balance carried down | 13,357.00 | 11,725.00 | 10,922.00 | 9,967.53 | 7,588.31 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 1,500.00 | 1,500.00 | 1,500.00 | 1,500.00 | 1,000.00 |
| Dividend Per Share(Rs) | 30.00 | 30.00 | 30.00 | 30.00 | 20.00 |
| Earnings Per Share-Unit Curr | 83.36 | 59.47 | 68.23 | 111.08 | 73.64 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 562.08 | 508.83 | 479.43 | 440.44 | 349.28 |
| Book Value(Adj)-Unit Curr | 562.08 | 508.83 | 479.43 | 440.44 | 349.28 |